147 related articles for article (PubMed ID: 28130401)
1. Distinctive Histogenesis and Immunological Microenvironment Based on Transcriptional Profiles of Follicular Dendritic Cell Sarcomas.
Laginestra MA; Tripodo C; Agostinelli C; Motta G; Hartmann S; Döring C; Rossi M; Melle F; Sapienza MR; Tabanelli V; Pileri A; Fuligni F; Gazzola A; Mannu C; Sagramoso CA; Lonardi S; Lorenzi L; Bacci F; Sabattini E; Borges A; Simonitsch-Klupp I; Cabecadas J; Campo E; Rosai J; Hansmann ML; Facchetti F; Pileri SA
Mol Cancer Res; 2017 May; 15(5):541-552. PubMed ID: 28130401
[TBL] [Abstract][Full Text] [Related]
2. miRNA expression profiling divides follicular dendritic cell sarcomas into two groups, related to fibroblasts and myopericytomas or Castleman's disease.
Hartmann S; Döring C; Agostinelli C; Portscher-Kim SJ; Lonardi S; Lorenzi L; Fuligni F; Martinez D; Mehta J; Borges A; Hackstein H; Kippenberger S; Piccaluga PP; Simonitsch-Klupp I; Cabeçadas J; Campo E; Facchetti F; Pileri SA; Hansmann ML
Eur J Cancer; 2016 Sep; 64():159-66. PubMed ID: 27423414
[TBL] [Abstract][Full Text] [Related]
3. Identification of novel follicular dendritic cell sarcoma markers, FDCSP and SRGN, by whole transcriptome sequencing.
Lorenzi L; Döring C; Rausch T; Benes V; Lonardi S; Bugatti M; Campo E; Cabeçadas J; Simonitsch-Klupp I; Borges A; Mehta J; Agostinelli C; Pileri SA; Facchetti F; Hansmann ML; Hartmann S
Oncotarget; 2017 Mar; 8(10):16463-16472. PubMed ID: 28145886
[TBL] [Abstract][Full Text] [Related]
4. Follicular dendritic cell sarcoma: clinicopathologic study of 15 cases with emphasis on novel expression of MDM2, somatostatin receptor 2A, and PD-L1.
Agaimy A; Michal M; Hadravsky L; Michal M
Ann Diagn Pathol; 2016 Aug; 23():21-8. PubMed ID: 27402219
[TBL] [Abstract][Full Text] [Related]
5. Histiocytic and dendritic cell neoplasms: Reappraisal of a Japanese series based on t(14;18) and neoplastic PD-L1 expression.
Okada K; Takahara T; Suzuki Y; Kohno K; Sakakibara A; Satou A; Takahashi E; Nakamura S
Pathol Int; 2021 Jan; 71(1):24-32. PubMed ID: 33238073
[TBL] [Abstract][Full Text] [Related]
6. Epidermal growth factor receptor expression in follicular dendritic cells: a shared feature of follicular dendritic cell sarcoma and Castleman's disease.
Sun X; Chang KC; Abruzzo LV; Lai R; Younes A; Jones D
Hum Pathol; 2003 Sep; 34(9):835-40. PubMed ID: 14562277
[TBL] [Abstract][Full Text] [Related]
7. Dysplastic follicular dendritic cells in hyaline-vascular Castleman disease: a rare occurrence creating diagnostic difficulty.
Medina EA; Fuehrer NE; Miller FR; Kinney MC; Higgins RA
Pathol Int; 2016 Sep; 66(9):535-9. PubMed ID: 27593552
[TBL] [Abstract][Full Text] [Related]
8. Identification of CXCL13 as a new marker for follicular dendritic cell sarcoma.
Vermi W; Lonardi S; Bosisio D; Uguccioni M; Danelon G; Pileri S; Fletcher C; Sozzani S; Zorzi F; Arrigoni G; Doglioni C; Ponzoni M; Facchetti F
J Pathol; 2008 Nov; 216(3):356-64. PubMed ID: 18792075
[TBL] [Abstract][Full Text] [Related]
9. T-cell infiltration and clonality correlate with programmed cell death protein 1 and programmed death-ligand 1 expression in patients with soft tissue sarcomas.
Pollack SM; He Q; Yearley JH; Emerson R; Vignali M; Zhang Y; Redman MW; Baker KK; Cooper S; Donahue B; Loggers ET; Cranmer LD; Spraker MB; Seo YD; Pillarisetty VG; Ricciotti RW; Hoch BL; McClanahan TK; Murphy E; Blumenschein WM; Townson SM; Benzeno S; Riddell SR; Jones RL
Cancer; 2017 Sep; 123(17):3291-3304. PubMed ID: 28463396
[TBL] [Abstract][Full Text] [Related]
10. Follicular dendritic cell sarcoma.
Facchetti F; Simbeni M; Lorenzi L
Pathologica; 2021 Oct; 113(5):316-329. PubMed ID: 34837090
[TBL] [Abstract][Full Text] [Related]
11. Characterization of human FDCs reveals regulation of T cells and antigen presentation to B cells.
Heesters BA; van Megesen K; Tomris I; de Vries RP; Magri G; Spits H
J Exp Med; 2021 Oct; 218(10):. PubMed ID: 34424268
[TBL] [Abstract][Full Text] [Related]
12. Cellular and molecular regulation of the programmed death-1/programmed death ligand system and its role in multiple sclerosis and other autoimmune diseases.
Ibañez-Vega J; Vilchez C; Jimenez K; Guevara C; Burgos PI; Naves R
J Autoimmun; 2021 Sep; 123():102702. PubMed ID: 34311143
[TBL] [Abstract][Full Text] [Related]
13. [Clinical pathologic characteristics of extranodal follicular dendritic cell sarcoma].
Cui LF; Zhang JX; Li Z; Gao Y; Lu T; Zhao HY; Zhong DR
Zhonghua Zhong Liu Za Zhi; 2019 Mar; 41(3):218-222. PubMed ID: 30917459
[No Abstract] [Full Text] [Related]
14. High frequency of clonal IG and T-cell receptor gene rearrangements in histiocytic and dendritic cell neoplasms.
Huang W; Qiu T; Zeng L; Zheng B; Ying J; Feng X
Oncotarget; 2016 Nov; 7(48):78355-78362. PubMed ID: 27823979
[TBL] [Abstract][Full Text] [Related]
15. Histiocytic and Dendritic Cell Sarcomas of Hematopoietic Origin Share Targetable Genomic Alterations Distinct from Follicular Dendritic Cell Sarcoma.
Massoth LR; Hung YP; Ferry JA; Hasserjian RP; Nardi V; Nielsen GP; Sadigh S; Venkataraman V; Selig M; Friedmann AM; Samore W; Killian JK; Milante R; Giessinger J; Foley-Peres K; Marcus C; Severson E; Duncan D; Sivakumar S; Ross JS; Desphande V; Ramkissoon SH; Vergilio JA; Louissaint A; Zukerberg LR; Williams EA
Oncologist; 2021 Jul; 26(7):e1263-e1272. PubMed ID: 33904632
[TBL] [Abstract][Full Text] [Related]
16. Programmed Death Ligand 1 (PD-L1) Expression in Malignant Mesenchymal Tumors.
Kösemehmetoğlu K; Özoğul E; Babaoğlu B; Tezel GG; Gedikoğlu G
Turk Patoloji Derg; 2017; 1(1):192-197. PubMed ID: 28832074
[TBL] [Abstract][Full Text] [Related]
17. γ-Synuclein is a promising new marker for staining reactive follicular dendritic cells, follicular dendritic cell sarcoma, Kaposi sarcoma, and benign and malignant vascular tumors.
Zhang H; Maitta RW; Bhattacharyya PK; Florea AD; Sen F; Wang Q; Ratech H
Am J Surg Pathol; 2011 Dec; 35(12):1857-65. PubMed ID: 21959308
[TBL] [Abstract][Full Text] [Related]
18. Human decidual stromal cells secrete C-X-C motif chemokine 13, express B cell-activating factor and rescue B lymphocytes from apoptosis: distinctive characteristics of follicular dendritic cells.
Muñoz-Fernández R; Prados A; Leno-Durán E; Blázquez A; García-Fernández JR; Ortiz-Ferrón G; Olivares EG
Hum Reprod; 2012 Sep; 27(9):2775-84. PubMed ID: 22718279
[TBL] [Abstract][Full Text] [Related]
19. Podoplanin (d2-40): a new immunohistochemical marker for reactive follicular dendritic cells and follicular dendritic cell sarcomas.
Xie Q; Chen L; Fu K; Harter J; Young KH; Sunkara J; Novak D; Villanueva-Siles E; Ratech H
Int J Clin Exp Pathol; 2008 Jan; 1(3):276-84. PubMed ID: 18784810
[TBL] [Abstract][Full Text] [Related]
20. Expression of Programmed Cell Death 1 Ligands (PD-L1 and PD-L2) in Histiocytic and Dendritic Cell Disorders.
Xu J; Sun HH; Fletcher CD; Hornick JL; Morgan EA; Freeman GJ; Hodi FS; Pinkus GS; Rodig SJ
Am J Surg Pathol; 2016 Apr; 40(4):443-53. PubMed ID: 26752545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
